Back to search

Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis

Data up to Jan 2025

Published1990
Citations76
References39

Total Citations Per Year

Abstract

References (39)

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1980 • 4,703 citations

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

1981 • 1,366 citations

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

1985 • 1,143 citations

Expression of interleukin 2 receptors on activated human B cells.

1984 • 488 citations

Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

1983 • 453 citations

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

1982 • 421 citations

Lymphocytes in the skin of patients with progressive systemic sclerosis

1984 • 369 citations

The released interleukin 2 receptor binds interleukin 2 efficiently.

1986 • 348 citations

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

1985 • 288 citations

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

1988 • 274 citations

Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

1987 • 245 citations

Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.

1988 • 162 citations

An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro

1986 • 161 citations

Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus

1984 • 159 citations

Lymphotoxin Is an Important T Cell-Derived Growth Factor for Human B Cells

1987 • 151 citations

Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration

1989 • 134 citations

Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases

1989 • 121 citations

Silicone and rheumatic diseases

1987 • 112 citations

A syndrome resembling progressive systemic sclerosis after bone marrow transplantation

1979 • 105 citations

Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferation

1988 • 98 citations

Purification of human B cell growth factor.

1985 • 95 citations

Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.

1988 • 92 citations

Interstitial lung disease in scleroderma analysis by bronchoalveolar lavage

1984 • 90 citations

Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis

1988 • 89 citations

Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.

1985 • 88 citations

Scleroderma

1983 • 74 citations

Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications.

1988 • 63 citations

Polyclonal B lymphocyte activation in progressive systemic sclerosis.

1989 • 55 citations

Cellular immunity to collagen and laminin in scleroderma

1985 • 52 citations

Enhanced production of interleukin‐2 in patients with progressive systemic sclerosis. hyperactivity of cd4‐positive t cells?

1988 • 51 citations

Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.

1987 • 50 citations

Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice.

1987 • 47 citations

Regulation of interleukin-2 receptor expression and receptor release

1986 • 43 citations

Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).

1985 • 40 citations

Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases

1984 • 38 citations

Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis

1990 • 21 citations

Activation,Proliferation and Differentiation of Human B Lymphocytes

1985 • 18 citations

Mononuclear cell-fibroblast interactions in scleroderma

1988 • 16 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants… (1990) – Clinical & Experimental Immunology | Metascience Observatory Explorer